Johnson and Johnson and its DePuy subsidiary agreed to pay $120 million to settle multistate lawsuits alleging false claims and unfair marketing of their metal-on-metal hip implant devices.
The 46 states that accused DePuy of making false claims about the longevity of the ASR XL and Pinnacle Ultamet metal-on-metal hip implant devices will share the settlement. Texas, for example, will receive $8.5 million.
Under the agreement, DePuy will reevaluate and revise its marketing and promotion strategies for the hip implants, including its use of scientific data to support advertising claims. The company said the settlement involves no admission of liability or misconduct.